P2X and P2Y nucleotide receptors as targets in cardiovascular disease
- 1 March 2013
- journal article
- review article
- Published by Future Science Ltd in Future Medicinal Chemistry
- Vol. 5 (4), 431-449
- https://doi.org/10.4155/fmc.13.6
Abstract
Endogenous nucleotides have widespread actions in the cardiovascular system, but it is only recently that the P2X and P2Y receptor subtypes, at which they act, have been identified and subtype-selective agonists and antagonists developed. These advances have greatly increased our understanding of the physiological and pathophysiological functions of P2X and P2Y receptors, but investigation of the clinical usefulness of selective ligands is at an early stage. Nonetheless, the evidence considered in this review demonstrates clearly that various cardiovascular disorders, including vasospasm, hypertension, congestive heart failure and cardiac damage during ischemic episodes, may be viable targets. With further development of novel, selective agonists and antagonists, our understanding will continue to improve and further therapeutic applications are likely to be discovered.Keywords
This publication has 98 references indexed in Scilit:
- UDP-glucose acting at P2Y14 receptors is a mediator of mast cell degranulationBiochemical Pharmacology, 2010
- Human P2Y14 Receptor Agonists: Truncation of the Hexose Moiety of Uridine-5′-Diphosphoglucose and Its Replacement with Alkyl and Aryl GroupsJournal of Medicinal Chemistry, 2009
- Pore architecture and ion sites in acid-sensing ion channels and P2X receptorsNature, 2009
- Crystal structure of the ATP-gated P2X4 ion channel in the closed stateNature, 2009
- Synthesis and potency of novel uracil nucleotides and derivatives as P2Y2 and P2Y6 receptor agonistsBioorganic & Medicinal Chemistry, 2008
- P2 receptors in cardiovascular regulation and diseasePurinergic Signalling, 2007
- Structure−Activity Relationship of Uridine 5‘-Diphosphoglucose Analogues as Agonists of the Human P2Y14 ReceptorJournal of Medicinal Chemistry, 2007
- Molecular Modeling of the Human P2Y2 Receptor and Design of a Selective Agonist, 2‘-Amino-2‘-deoxy-2-thiouridine 5‘-TriphosphateJournal of Medicinal Chemistry, 2007
- Structure−Activity Relationships of Uridine 5‘-Diphosphate Analogues at the Human P2Y6 ReceptorJournal of Medicinal Chemistry, 2006
- The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significancePurinergic Signalling, 2006